RT Journal Article
SR Electronic
T1 Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMB
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007339
DO 10.1136/jitc-2023-007339
VO 11
IS 11
A1 He, Jie
A1 Kalinava, Natallia
A1 Doshi, Parul
A1 Pavlick, Dean C
A1 Albacker, Lee A
A1 Ebot, Ericka M
A1 Tukachinsky, Hanna
A1 Pratt, James
A1 Fusaro, Gina
A1 Oxnard, Geoffrey R
A1 Green, George
A1 Fabrizio, David
A1 Baden, Jonathan
YR 2023
UL http://jitc.bmj.com/content/11/11/e007339.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.